National Institutes of Health: Hearing Loss trials

The registry lists 15 Hearing Loss studies with National Institutes of Health as lead sponsor. 4 are open to participants now and 1 have results posted.

Phase 2 2Phase 3 1No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• NIDCD Otolaryngology Clinical Protocol Biospecimen BankRecruitingNCT06303180
• Collection of Clinical Data and Specimens for Research in Hearing, Balance, Taste, Smell, Voice, Speech, and Language Disorders.RecruitingNCT05670496
• Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck CancerRecruitingNCT04915183Phase 2
• Natural History of Autosomal Dominant Hearing LossRecruitingNCT04501081
• Valganciclovir Therapy in Infants and Children With Congenital CMV Infection and Hearing LossCompletedNCT01649869Phase 2Results posted
• Hearing Loss and the Effects of Statin Drugs in People With Head and Neck Squamous Cell Carcinoma Treated With Cisplatin ChemoradiationCompletedNCT03225157
• Natural History and Genetic Studies of Usher SyndromeCompletedNCT00106743
• Genetic Analysis of Hereditary Disorders of Hearing and BalanceCompletedNCT00023049
• Clinical and Genetic Analysis of Enlarged Vestibular AqueductsCompletedNCT00023036
• A Genetic Analysis of Usher Syndrome in Ashkenazi JewsCompletedNCT00016471
• Genetic Studies of Tone DeafnessCompletedNCT00006076
• Areas of Brain Responsible for Understanding American Sign LanguageCompletedNCT00001782
• Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac TumorsCompletedNCT00001668
• Genetic Analysis of Human Hereditary Hearing ImpairmentTerminatedNCT00001606
• Autoimmunity in Inner Ear DiseaseTerminatedNCT00000361Phase 3